Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan

Abstract Previous studies have shown that aspirin is effective as a prophylactic agent against venous thromboembolism (VTE) following proximal femoral fractures (PFF). In Japan, there is a lack of evidence regarding its efficacy and safety in this context. Consequently, aspirin is not covered by ins...

Full description

Saved in:
Bibliographic Details
Main Authors: Takao Ohmori, Kazukiyo Toda, Takuya Taoka, Takeshi Ishihara, Yasuo Ito
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88493-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862480920641536
author Takao Ohmori
Kazukiyo Toda
Takuya Taoka
Takeshi Ishihara
Yasuo Ito
author_facet Takao Ohmori
Kazukiyo Toda
Takuya Taoka
Takeshi Ishihara
Yasuo Ito
author_sort Takao Ohmori
collection DOAJ
description Abstract Previous studies have shown that aspirin is effective as a prophylactic agent against venous thromboembolism (VTE) following proximal femoral fractures (PFF). In Japan, there is a lack of evidence regarding its efficacy and safety in this context. Consequently, aspirin is not covered by insurance for the prevention of venous thrombosis. This study aimed to investigate whether continued aspirin use in patients with PFF, who were already taking aspirin for cerebrovascular disease prevention before injury is effective as a prophylaxis for deep vein thrombosis (DVT). We retrospectively analyzed PFF patients (≥ 65 years) who underwent postoperative duplex ultrasonography from January 2010 to December 2023.The study compared patients taking aspirin alone (aspirin group) and those not taking antiplatelet agents or anticoagulants (control group), matched by propensity scores. We enrolled 1064 patients while 161 (15%) were in the aspirin group. After matching, 128 patients were analyzed. DVT incidence was not statistically significant between the aspirin (54) and control groups (60) (OR: 0.81; 95%CI: 0.49- 1.36; p = 0.44). Proximal DVT incidence was also similar (OR: 2; 95%CI: 0.50–7.00; p = 0.33). Additionally, since use of other postoperative antithrombotic prophylaxis (78%) is thought to have a significant impact on the incidence of DVT, a subgroup analysis was conducted to evaluate the effect of aspirin in patients who did not receive postoperative antithrombotic prophylaxis. Similarly, there was no statistically significant difference in either DVT (OR: 1.38; 95% CI: 0.55–3.42; p = 0.49) or proximal DVT (OR: 2.00; 95% CI: 0.37–10.92; p = 0.42). This study demonstrates that aspirin is not effective for preventing VTE in patients with PFF in Japan.
format Article
id doaj-art-6148878f48df4780996fc103bd71b456
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-6148878f48df4780996fc103bd71b4562025-02-09T12:31:31ZengNature PortfolioScientific Reports2045-23222025-02-011511810.1038/s41598-025-88493-4Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in JapanTakao Ohmori0Kazukiyo Toda1Takuya Taoka2Takeshi Ishihara3Yasuo Ito4Department of Orthopaedic Surgery, Japanese Red Cross Kobe HospitalDepartment of Orthopaedic Surgery, Japanese Red Cross Kobe HospitalDepartment of Orthopaedic Surgery, Japanese Red Cross Kobe HospitalDepartment of Orthopaedic Surgery, Japanese Red Cross Kobe HospitalDepartment of Orthopaedic Surgery, Japanese Red Cross Kobe HospitalAbstract Previous studies have shown that aspirin is effective as a prophylactic agent against venous thromboembolism (VTE) following proximal femoral fractures (PFF). In Japan, there is a lack of evidence regarding its efficacy and safety in this context. Consequently, aspirin is not covered by insurance for the prevention of venous thrombosis. This study aimed to investigate whether continued aspirin use in patients with PFF, who were already taking aspirin for cerebrovascular disease prevention before injury is effective as a prophylaxis for deep vein thrombosis (DVT). We retrospectively analyzed PFF patients (≥ 65 years) who underwent postoperative duplex ultrasonography from January 2010 to December 2023.The study compared patients taking aspirin alone (aspirin group) and those not taking antiplatelet agents or anticoagulants (control group), matched by propensity scores. We enrolled 1064 patients while 161 (15%) were in the aspirin group. After matching, 128 patients were analyzed. DVT incidence was not statistically significant between the aspirin (54) and control groups (60) (OR: 0.81; 95%CI: 0.49- 1.36; p = 0.44). Proximal DVT incidence was also similar (OR: 2; 95%CI: 0.50–7.00; p = 0.33). Additionally, since use of other postoperative antithrombotic prophylaxis (78%) is thought to have a significant impact on the incidence of DVT, a subgroup analysis was conducted to evaluate the effect of aspirin in patients who did not receive postoperative antithrombotic prophylaxis. Similarly, there was no statistically significant difference in either DVT (OR: 1.38; 95% CI: 0.55–3.42; p = 0.49) or proximal DVT (OR: 2.00; 95% CI: 0.37–10.92; p = 0.42). This study demonstrates that aspirin is not effective for preventing VTE in patients with PFF in Japan.https://doi.org/10.1038/s41598-025-88493-4Proximal femoral fracturesDeep vein thrombosisAspirinProphylaxisSurgery
spellingShingle Takao Ohmori
Kazukiyo Toda
Takuya Taoka
Takeshi Ishihara
Yasuo Ito
Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan
Scientific Reports
Proximal femoral fractures
Deep vein thrombosis
Aspirin
Prophylaxis
Surgery
title Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan
title_full Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan
title_fullStr Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan
title_full_unstemmed Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan
title_short Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan
title_sort effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in japan
topic Proximal femoral fractures
Deep vein thrombosis
Aspirin
Prophylaxis
Surgery
url https://doi.org/10.1038/s41598-025-88493-4
work_keys_str_mv AT takaoohmori effectivenessofaspirininpreventingdeepveinthrombosisfollowingproximalfemoralfracturesurgeryinjapan
AT kazukiyotoda effectivenessofaspirininpreventingdeepveinthrombosisfollowingproximalfemoralfracturesurgeryinjapan
AT takuyataoka effectivenessofaspirininpreventingdeepveinthrombosisfollowingproximalfemoralfracturesurgeryinjapan
AT takeshiishihara effectivenessofaspirininpreventingdeepveinthrombosisfollowingproximalfemoralfracturesurgeryinjapan
AT yasuoito effectivenessofaspirininpreventingdeepveinthrombosisfollowingproximalfemoralfracturesurgeryinjapan